EMCDDA Home
  • EN
Search

Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2011 or most recent year available

Part (vi) All volatile inhalant outpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium25100001909
Bulgaria02002410909
Czech Republic03000200505
Denmark02010013707
Germany111411101021160060
Estonia41:::::::::
Ireland18812100020020
Greece02000010303
Spain135162110670272
France57171020511::::
Italy20070800015015
Cyprus00000000000
Latvia314261222710082082
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary0684230023023
Malta:21::::::::
Netherlands0232111212012
Austria01000000101
Poland4::::1::::::
Portugal500010000101
Romania01010000202
Slovenia:::::::::::
Slovakia4832211021021
Finland01000000101
Sweden101000000101
United Kingdom61141173121181810103390339
Croatia000110002::
Turkey:::::::::::
Norway700100000101
Total16526010279743827236842684
 

Notes:

: Indicates no data available.

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

(7) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-10 part(iii), part(iv)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013